JP Morgan Chase
LEGN icon

JP Morgan Chase’s Legend Biotech LEGN Stock Holding History

JP Morgan Chase’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,000
Closed -$522K – 7733
2025
Q4 		$522K Buy
+24,000
New +$687K ﹤0.01% 4992
2024
Q1 		– Sell
-190,000
Closed -$11.4M – 7669
2023
Q4 		$11.4M Buy
+190,000
New +$12M ﹤0.01% 2339
2023
Q2 		– Sell
-31,000
Closed -$1.5M – 7152
2023
Q1 		$1.5M Sell
31,000
-171,000
-85% -$8.36M ﹤0.01% 3750
2022
Q4 		$10.1M Sell
202,000
-36,500
-15% -$1.77M ﹤0.01% 2244
2022
Q3 		$9.73M Hold
238,500
– – ﹤0.01% 2164
2022
Q2 		$13.1M Hold
238,500
– – ﹤0.01% 1945
2022
Q1 		$8.67M Buy
+238,500
New +$9.42M ﹤0.01% 2518
2021
Q3 		– Sell
-30,000
Closed -$1.23M – 6654
2021
Q2 		$1.23M Buy
+30,000
New +$1.02M ﹤0.01% 4151

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

JP Morgan Chase's LEGN Position: Q1 2026 in Review

JP Morgan Chase reduced its Legend Biotech (LEGN) stake by 70% in Q1 2026, selling an estimated $12.5M and leaving 288,103 shares worth $4.99M. The position accounts for ﹤0.01% of the portfolio, ranked #3297.

JP Morgan Chase first reported a position in LEGN in Q2 2020 and has held it in 24 quarters since. The position peaked at $39.7M in Q2 2023. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • JP Morgan Chase held 288,103 shares of Legend Biotech worth $4.99M as of Q1 2026.
  • JP Morgan Chase sold 657,591 Legend Biotech shares in Q1 2026, an estimated $12.5M.
  • Legend Biotech made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3297 holding.
  • JP Morgan Chase first reported a position in Legend Biotech in Q2 2020 and has held it in 24 quarters since.
  • JP Morgan Chase's Legend Biotech position peaked at $39.7M in Q2 2023.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.